Can a Two-Session education program ease stress in High-Risk pregnancies?
NCT ID NCT07820306
First seen Sep 15, 2026 · Last updated Sep 16, 2026 · Updated 1 time
Summary
Researchers are testing whether a structured prenatal education program based on the Roy Adaptation Model can reduce stress and improve quality of life for pregnant women with hypertensive disorders. The study enrolls 54 pregnant women between 20 and 32 weeks of gestation who have been diagnosed with a hypertensive disorder of pregnancy. Participants are randomly assigned to either receive two face-to-face education sessions one week apart or receive routine antenatal care. The education covers blood pressure monitoring, healthy lifestyle habits, stress management, and adapting to physical and emotional changes during pregnancy. Researchers measure perceived stress and pregnancy-related quality of life before and after the program.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Roy Adaptation Model-based prenatal education, a structured two-session face-to-face program
- What this could lead to
- If it works, this could give pregnant women with high blood pressure a low-risk, non-drug way to manage stress and feel better during pregnancy.
- What could go wrong
- The trial is small and measures stress and quality of life through questionnaires, so results may reflect how women feel rather than hard health outcomes. Education alone may not be enough for women with severe hypertension.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 54 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Sep 2026
An estimate. Start dates often move.
- Expected to finish
-
Jan 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 45 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Pregnant women who apply to the antenatal outpatient clinic of the relevant hospital. * Women diagnosed by a physician with a hypertensive disorder of pregnancy. Women who are between 20 and 32 weeks of gestation. * Women aged 18 years or older. * Primiparous or multiparous pregnant women. * Women who can read and understand Turkish and communicate in Turkish. * Women who are willing to participate in the study. Exclusion Criteria: * Pregnant women with severe preeclampsia, eclampsia, HELLP syndrome, or a clinical condition requiring emergency obstetric intervention. * Pregnant women who are hospitalized or scheduled for hospitalization at the beginning of the study. * Pregnant women diagnosed with fetal anomaly or intrauterine fetal death. * Pregnant women with severe psychiatric, neurological, or cognitive impairment that may prevent participation in the education sessions or completion of the data collection instruments. * Pregnant women who develop a serious obstetric or clinical complication during the study that may affect the primary outcomes of the study.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Hypertensive disorders of pregnancy (HDP) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Prof. Dr. Cemil Taşcıoğlu Şehir Hastanesi
Istanbul, 34384, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Simple doctor alert could prevent deadly pregnancy complication
- Can a phone app slash pregnancy care costs? new study aims to find out
- Phone coaching and home monitoring aim to tame high blood pressure in women after preeclampsia
- Can remote monitoring and community support tame postpartum high blood pressure?
- App aims to ease postpartum hypertension and depression